Icono de la app AgingResearch.News: Longevity

The fastest way to know what really works in longevity

De PAPERFOOT AI PTE. LTD. · Social
Puntuación de Debuts 76NuevaSé el primero en valorarla

Por qué la esperamos: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

Captura de pantalla 1 de AgingResearch.News: LongevityCaptura de pantalla 2 de AgingResearch.News: LongevityCaptura de pantalla 3 de AgingResearch.News: LongevityCaptura de pantalla 4 de AgingResearch.News: LongevityCaptura de pantalla 5 de AgingResearch.News: Longevity

Apps de Social similares

Ver las mejores

En resumen

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Resumen de Debuts, basado en la ficha de la App Store.

Acerca de

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Preguntas sobre AgingResearch.News: Longevity

¿Qué es AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
¿AgingResearch.News: Longevity es gratis?
Sí. AgingResearch.News: Longevity se puede descargar gratis.
¿En qué dispositivos funciona AgingResearch.News: Longevity?
AgingResearch.News: Longevity funciona en iPhone, iPad.
¿En qué idiomas está disponible AgingResearch.News: Longevity?
AgingResearch.News: Longevity está disponible en 11 idiomas, entre ellos alemán, inglés, español, francés, italiano, japonés.
¿Quién crea AgingResearch.News: Longevity?
AgingResearch.News: Longevity es obra de PAPERFOOT AI PTE. LTD.. La clasificación por edad en App Store es 12+.
¿Qué alternativas hay a AgingResearch.News: Longevity?
Apps similares en Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Así la valora la gente

Inicia sesión para valorar esta app. Lo que cuenta es ser sincero.

Aún no hay valoraciones. ¿La has probado? Sé el primero en valorarla.

Señales de descubrimiento

Cómo descubren AgingResearch.News: Longevity la IA y las personas en Debuts
Lista para IAParcial
78% descrita para que la IA la encuentre
Descubrible ahoraActivaDatos estructurados en esta página y la API de Debuts

Cuéntanos qué te gusta. Solo te escribimos cuando hay algo nuevo que encaja, y los creadores suelen añadir una ventaja para los probadores.

Qué tipo de apps
En mi
Mostrarme solo
Con qué frecuencia
Te enviamos un enlace para confirmar. No recibirás nada hasta que hagas clic.